Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.05 USD | +0.33% | -6.23% | -21.62% |
10/05 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
09/05 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.62% | 214.65Cr | |
+18.41% | 8.31TCr | |
-29.08% | 7.09TCr | |
+3.59% | 2.83TCr | |
-7.08% | 1.77TCr | |
+2.07% | 1.74TCr | |
+0.93% | 1.56TCr | |
+6.78% | 1.35TCr | |
+8.40% | 1.28TCr | |
+68.45% | 1.27TCr |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group Insider Sold Shares Worth $454,432, According to a Recent SEC Filing